You can buy or sell SSMXY and other stocks, options, ETFs, and crypto commission-free!
Sysmex Corp. engages in the development, manufacture, import, export, and sale of clinical laboratory instruments, reagents, and software used in in-vitro diagnostics. It also provides clinical laboratory testing of blood, urine, and other specimens. Read More Its products include instruments and reagents diagnostics for hemostasis, immunochemistry, clinical chemistry, urinalysis, and point-of-care (POC) testing. It operates through the following geographical segments: Japan, Americas, EMEA, China, and Asia Pacific. The company was founded on February 20, 1968 and is headquartered in Kobe, Japan. SSMXY is listed on the Pink Current market tier. OTC market data is provided by OTC Markets Group, Inc (otcmarkets.com).
52 Week High
52 Week Low
PR NewswireFeb 26
Japan IVD Market Report 2019 - Sysmex Corporation is the Leader, Followed by Roche Diagnostics
DUBLIN, Feb. 26, 2019 /PRNewswire/ -- The "Japan IVD Market Size, Share, Major Deals & Company Analysis - Forecast to 2025" report has been added to ResearchAndMarkets.com's offering. Japanese In Vitro Diagnostics (IVD) market is expected to surpass US$ 4.3 Billion mark by 2025 Japan represents one of the largest clinical laboratory markets in the Asia-Pacific region, and the fastest growing among the top ten IVD country markets. With an aging population, technological advances and advent of point of care...